Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Hongtao Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 2
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees Soon

Areas of investment

  • Biotechnology
  • Biopharma
  • Medical
  • Drug Discovery
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hongtao Capital:
Typical Co-investors
Hongtao Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hongtao Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ABeam Consulting Japan, Tokyo
ATPI England, London, United Kingdom
Beijing Benywave Technology Beijing, Beijing, China
Blue Horizon Equity California, San Francisco, United States
C.M. Capital Advisors California, Palo Alto, United States
Chernovetskyi Investment Group -
Cordet England, London, United Kingdom
DD Holdings Japan, Tokyo
DongtuShengtang Investment China, Guangdong, Shenzhen
Group One -
Kaleden Holdings -
Kidron New York, New York, United States
Monitor Ventures California, Los Angeles, United States
One Boat Capital -
PointOne Capital Bengaluru, India, Karnataka
Sagebrook Technology Dallas, Texas, United States
Xianchang Investment China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hongxin Biology

Biopharma
Biotechnology
Medical
16 Jan 2024 Shenzhen, Guangdong, China

Hongxin Biology

Biopharma
Biotechnology
Medical
30 Dec 2022 Shenzhen, Guangdong, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hongtao Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 35M
Peak activity year 2022
Lead investments 1
Follow on index 0.33
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Hongxin Biology

Biopharma
Biotechnology
Medical
16 Jan 2024 Shenzhen, Guangdong, China

Hongxin Biology

Biopharma
Biotechnology
Medical
30 Dec 2022 Shenzhen, Guangdong, China
Crunchbase icon

Content report

The following text will be sent to our editors: